Dr. Cemal Karakas, MD

  • Washington, DC
  • Epilepsy physician
NPI1831550243
Part D claims, 2024
96
Publications
40
MIPS score, 2024
100
Hospital affiliations
1
Industry payments
$814
Practice address
111 Michigan Ave, NW, Washington, DC 20010
Practice phone
Call (202) 476-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Children's National Hospital

Hospital · Washington, District of Columbia

See all 5 affiliations

Find Dr. Karakas' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Cemal Karakas is an epilepsy physician in Washington, District of Columbia

Dr. Karakas practices at Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital.

Dr. Karakas' NPI, 1831550243, was assigned on March 11, 2016. Dr. Karakas holds Kentucky license 1938.

NPI and contact details
NPI enumeration date
March 11, 2016
NPI status
Active
Practice phone
(202) 476-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Cemal Karakas practices at Children's National Hospital in Washington, District of Columbia

Dr. Karakas' primary practice is Children's National Hospital, at 111 Michigan Ave, NW, Washington, DC 20010 in The District County. The practice phone is (202) 476-5000.

Source: Dmand AI Affiliation Data

Dr. Cemal Karakas is affiliated with 3 sites of care and 2 medical groups

Dr. Karakas' primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. The medical group on file is Children's National Hospital. Dmand AI also links Dr. Karakas to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

See all 5 affiliations for Dr. Karakas

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Cemal Karakas' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karakas practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Children's National HospitalAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Karakas practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Children's National Hospital and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Cemal Karakas is one of 3 epilepsy physicians in District of Columbia

Epilepsy is Dr. Karakas' primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Karakas is licensed in Kentucky.

Specialties and state licenses

  • Epilepsy, KentuckyPrimaryLicense 53165 · taxonomy 2084E0001X

Epilepsy physicians near Dr. Karakas

Counts of epilepsy physicians with a Dmand AI profile, by place and practice. Each opens the list.

3epilepsy physicians in District of Columbia
3epilepsy physicians in Washington
2epilepsy physicians at Children's National Hospital

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Cemal Karakas' patients have a median age of 9

Across all payers, Dmand AI patient panel data puts Dr. Karakas' median patient age at 9, with 43% women.

Dr. Karakas' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 9

Patient panel by sex, all payers

  • Women43%
  • Men56%

Source: Dmand AI Patient Panel Data

Dr. Cemal Karakas wrote 96 Medicare Part D claims in 2024

In 2024, Dr. Karakas wrote 96 Medicare Part D claims. 90% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $783 in total drug cost.

Part D claims, 202496
Drugs named by CMS2
Total drug cost$783

Dr. Karakas' Part D claims by kind of drug, 2024

  • Generic86 claims90%
  • Brand-name and other10 claims10%

Dr. Karakas' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

See all prescribing by Dr. Karakas

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Cemal Karakas scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Karakas for performance year 2024, reported as part of a group.

Dr. Karakas' MIPS scores, performance year 2024

  • 100of 100Final score
  • 97.1of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find epilepsy physicians like Dr. Karakas by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Cemal Karakas has 40 publications on record

Dmand AI links 40 papers to Dr. Karakas, published from 2014 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Epilepsy, Drug Resistant Epilepsy and Seizures. Dr. Karakas has published most often in Pediatr Neurol. Dr. Karakas' most frequent co-authors are Zulfi Haneef, MD, Samir Rameshchandra Karia, MD and Debopam Samanta, MD.

Papers40
Years published2014 to 2025

Dr. Karakas' papers by year, 2014 to 2025

Topics Dr. Karakas writes about most

  • Epilepsy
  • Drug Resistant Epilepsy
  • Seizures
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Electroencephalography
  • Sinus Thrombosis, Intracranial
  • Anticoagulants

Dr. Karakas' most frequent co-authors

Recent publications by Dr. Karakas

See all 40 publications and co-authors

See who Dr. Karakas researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Karakas works with, so you can find a warm path to the right epilepsy physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Cemal Karakas received $814 in industry payments from 2021 to 2025

CMS Open Payments shows 13 general payments to Dr. Karakas from 10 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Neurelis, Inc. paid the most, $234.

General payments to Dr. Karakas by program year, 2021 to 2025

Companies that paid Dr. Karakas the most, 2021 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Karakas

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Cemal Karakas's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesClinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Cemal Karakas

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Cemal Karakas' NPI number?

Dr. Cemal Karakas' NPI number is 1831550243. It was assigned on March 11, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Cemal Karakas?

Dr. Cemal Karakas is an epilepsy physician in Washington, District of Columbia. The primary specialty in the NPI Registry is Epilepsy Physician (taxonomy code 2084E0001X).

Where does Dr. Cemal Karakas practice?

Dr. Karakas practices at 111 Michigan Ave, NW, Washington, DC 20010. Dr. Karakas' primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. Dmand AI also links Dr. Karakas to 1 dialysis center, 1 group practice or clinic and 1 medical group.

What is Dr. Cemal Karakas' office phone number?

The practice phone on file for Dr. Karakas is (202) 476-5000.

What is Dr. Cemal Karakas' medical license number?

Dr. Karakas holds Kentucky license 1938.

Which hospitals is Dr. Cemal Karakas affiliated with?

Dr. Karakas practices at Children's National Hospital in Washington, District of Columbia.

What medical group is Dr. Cemal Karakas part of?

Dr. Karakas is linked to Children's National Hospital. Dmand AI links Dr. Karakas to 1 more medical group.

What is Dr. Cemal Karakas' MIPS score?

Dr. Karakas' MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

What drugs does Dr. Cemal Karakas prescribe most?

In 2024 Medicare Part D data, Dr. Karakas' most prescribed drugs by claims were Lamotrigine and Clobazam.

Has Dr. Cemal Karakas received payments from drug or device companies?

CMS Open Payments shows $814 in general payments to Dr. Karakas from 10 companies from 2021 to 2025. The largest total came from Neurelis, Inc.

Show 3 more questionsShow fewer questions

How long has Dr. Cemal Karakas been practicing?

Dr. Karakas graduated from medical school in 2011, 15 years ago.

Does Dr. Cemal Karakas do research?

Dmand AI links 40 publications to Dr. Karakas, published from 2014 to 2025.

Who does Dr. Cemal Karakas publish with?

Dr. Karakas' most frequent co-authors are Zulfi Haneef, MD (11 shared papers), Samir Rameshchandra Karia, MD (8 shared papers) and Debopam Samanta, MD (8 shared papers).

Selling to epilepsy practices?

See epilepsy physicians in District of Columbia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)